Company Search:
Advanced Search
Sponsored Links
Enzon Pharmaceuticals, Inc. Company Snapshot
Enzon Pharmaceuticals, Inc. operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Enzon Pharmaceuticals with three other companies in this sector in the United States: Vical Incorporated (2015 sales of $20.95 million of which 100% was Biopharmaceutical), Acceleron Pharma Inc ($18.10 million ), and Neurocrine Biosciences Inc ($19.77 million of which 100% was Therapeutics).

Sales Analysis. During the year ended December of 2015, sales at Enzon Pharmaceuticals were $17.46 million. This is a sharp decrease of 44.0% versus 2014, when the company's sales were $31.17 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Enzon Pharmaceuticals, Inc.
  Stock Performance Chart for Enzon Pharmaceuticals, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (2/17/2017): .36
(Figures in U.S. Dollars)
1 Week 3.5%   13 Weeks 5.0%  
4 Weeks -10.8%   52 Weeks -20.7%  
Enzon Pharmaceuticals, Inc. Key Data:
  Ticker: ENZN Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2015 Sales 17,456,000
(Year Ending Jan 2016).
Employees: 1
  Currency: U.S. Dollars Market Cap: 15,784,613
  Fiscal Yr Ends: December Shares Outstanding: 44,214,603
  Share Type: Common Closely Held Shares: 93,089
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.